We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Venn Life Sciences Holdings Plc | LSE:VENN | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.85 | 6.70 | 7.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
24/3/2016 08:20 | Bought in here at the open and very surprised that I was able to buy at only a tad over 20p , looking at the RNS releases this year it would seem that at last VENN are at an important turning point and momentum is building. There is a good chance that today's trading update will be an important catalyst imv. Hopefully my purchase will coincide with a turnaround. | interceptor2 | |
24/3/2016 08:10 | 10k for me & 5k for my sprogs | cocker | |
24/3/2016 08:06 | I don't think anyone is going to get the chance to top up that low again :-) | yorgi | |
24/3/2016 07:57 | That's a great RNS :-) | yorgi | |
24/3/2016 07:47 | Presume it will just get marked straight up to 24p to see what happens. | yump | |
24/3/2016 07:43 | Wow, I wish I had the balls to have added over recent weeks to my holding. Still not to late I guess, but market will be very bullish early on. | cocker | |
24/3/2016 07:27 | Looking good here on that update :-) " the Company now expects revenues for full year to 31 December 2015 to be significantly more than double the previous year (2014: €4.9m) and to exceed market expectations by at least 15%". | cheshire man | |
24/3/2016 07:15 | Yippee - results well ahead of expectations..... "the Company now expects revenues for full year to 31 December 2015 to be significantly more than double the previous year (2014: €4.9m) and to exceed market expectations by at least 15%" Plus a €3.4m cash pile. Plus a very bullish outlook. | rivaldo | |
10/3/2016 16:07 | I added a cheeky 25/- at lunchtime which moved the price slightly. | eburne1960 | |
10/3/2016 13:51 | Overhang gone? Let's hope so. | rivaldo | |
09/3/2016 13:44 | I've been adding in size here. Well below oversubscribed placing at 22p last year. Good progress since. | aishah | |
09/3/2016 10:49 | I guess so. But why? | shrout | |
09/3/2016 10:44 | There was a big sell a few weeks ago, maybe they are trying to sell more | tech | |
09/3/2016 10:40 | Down again today... ... can anyone shed any light on what's up with this stock? I know it's very illiquid and there appears to be a big overhang. But surely this price action is ridiculous for a company with such good prospects.. or so we are led to believe. | shrout | |
25/2/2016 17:29 | There is your answer to the sudden weakness the other day. 1.4 mil sale at 17.75p guessing around a 4-5p discount took given the sheer size of the block... desperate sale | sharetips6 | |
24/2/2016 13:55 | This video interview with the CEO from last month hasn't been posted here before and is well worth listening to: Http ://www.proactiveinve "Venn Life Sciences CEO focused on sizable deals 12:20 08 Jan 2016 Venn Life Sciences (LON:VENN) chief executive Tony Richardson says the biotech services company is focused on brining larger deals into its pipeline. “We’re now frequently bidding for contracts worth £1mln-2mln in value, which is a step up from where we were 18 months ago,” said Richardson. The firm told investors today that it expects revenues for the full year 2015 to be at least double the prior year, in which it had €4.9mln." | rivaldo | |
24/2/2016 07:51 | Completely agreed. There were around 150k shares available to buy online in the early afternoon yesterday from memory, which is most unusual, so I suspect this is simply a rather clumsily arranged sell order. with the MMs trying to find a level which will find buyers in a falling and illiquid general market. A buying opportunity imho. | rivaldo | |
23/2/2016 18:15 | looks like could be a disaster | dlku | |
23/2/2016 17:58 | I am not to sure you can pay any attention to buy/sell here on advfn as all to often mine are reported wrongly. I guess with such small volume it hardly matters unless someone has placed a large sell order, which I very much doubt. | cocker | |
23/2/2016 17:56 | No idea why the drop, but I bought 18K shares today that weren't shown on the trades list. | bollers | |
23/2/2016 17:15 | If everything's so wonderful why did the share price suddenly drop 16% today on no news, with buys apparently exceeding sales by 3 to 1? It makes no sense to me. Perhaps rationality is the wrong thing to expect in the crazy world of AIM. | shrout | |
09/2/2016 11:23 | A reminder that VENN were one of Techinvest's tips for 2016 - here's what they had to say: "Venn Life Sciences (VENN; 21.5p) was a New Year tip last year as well, albeit now 26.5% higher. But the evolving story has continued to develop nicely over the period since, while arguably the share price continues to lag events. Most recent Update notes were in the October (Page 4) and November (Page 1) issues, both written at 22.5p. Taken together, these make a compelling case. One senses the Company has now attained a reasonable critical mass - the €1m-plus French contract announced late October certainly supports this. Currently listed on AIM, the Dublin headquartered company will additionally be listed on ESM, the small companies part of the Dublin Stock Exchange, with effect from January 18. Allowing for the October placing, which raised £3.5m at 22p per share, the market cap is still a lowly £12.9m." | rivaldo |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions